Differential Genetic Associations for Systemic Lupus Erythematosus Based on Anti–dsDNA Autoantibody Production
Year: 2011
Type: article
Study design: Observational Study
Abstract: Systemic lupus erythematosus (SLE) is a clinically heterogeneous, systemic autoimmune disease characterized by autoantibody formation. Previously published genome-wide association studies (GWAS) have investigated SLE as a single phenotype. Therefore, we conducted a GWAS to identify genetic factors associated with anti-dsDNA autoantibody production, a SLE-related autoantibody with diagnostic and clinical importance. Using two independent datasets, over 400,000 single nucleotide polymorphisms (SNPs) were studied in a total of 1,717 SLE cases and 4,813 healthy controls. Anti-dsDNA autoantibody positive (anti-dsDNA +, n = 811) and anti-dsDNA autoantibody negative (anti-dsDNA -, n = 906) SLE cases were compared to healthy controls and to each other to identify SNPs associated specifically with these SLE subtypes. SNPs in the previously identified SLE susceptibility loci STAT4, IRF5, ITGAM, and the major histocompatibility complex were strongly associated with anti-dsDNA + SLE. Far fewer and weaker associations were observed for anti-dsDNA - SLE. For example, rs7574865 in STAT4 had an OR for anti-dsDNA + SLE of 1.77 (95% CI 1.57-1.99, p = 2.0E-20) compared to an OR for anti-dsDNA - SLE of 1.26 (95% CI 1.12-1.41, p = 2.4E-04), with p(heterogeneity)<0.0005. SNPs in the SLE susceptibility loci BANK1, KIAA1542, and UBE2L3 showed evidence of association with anti-dsDNA + SLE and were not associated with anti-dsDNA - SLE. In conclusion, we identified differential genetic associations with SLE based on anti-dsDNA autoantibody production. Many previously identified SLE susceptibility loci may confer disease risk through their role in autoantibody production and be more accurately described as autoantibody propensity loci. Lack of strong SNP associations may suggest that other types of genetic variation or non-genetic factors such as environmental exposures have a greater impact on susceptibility to anti-dsDNA - SLE.
Source: PLoS Genetics
Authors: Sharon A. Chung, Kimberly E. Taylor, Robert R. Graham, Joanne Nititham, Annette T. Lee, Ward A. Ortmann, Chaim O. Jacob, Marta E. Alarcón-Riquelme, Betty P. Tsao, John B. Harley, Patrick M. Gaffney, Kathy L. Moser, SLEGEN, Michelle Petri, F. Yesim Demirci, M. Ilyas Kamboh, Susan Manzi, Peter K. Gregersen, Carl D. Langefeld, Timothy W. Behrens, Lindsey A. Criswell
Institutions: University of California, San Francisco, Russell/Engleman Rheumatology Research Center, Genentech, Northwell Health, Feinstein Institute for Medical Research, University of Southern California, Uppsala University, Universidad de Granada, Oklahoma Medical Research Foundation, Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research, University of California, Los Angeles, Cincinnati Children's Hospital Medical Center, Veterans Health Administration, Johns Hopkins University, University of Pittsburgh, Johns Hopkins Medicine, Allegheny General Hospital, Allegheny-Singer Research Institute, Wake Forest University, Wake Forest University Health Sciences
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,043
Funders: U.S. Department of Veterans Affairs, University of Southern California, Wake Forest University, Cincinnati Children's Hospital Medical Center, Johns Hopkins University, University of Pittsburgh, Oklahoma Medical Research Foundation, Lupus Research Alliance, Broad Institute, Imperial College London, Knut och Alice Wallenbergs Stiftelse, Vetenskapsrådet, Reumatikerförbundet, National Institutes of Health, Genentech, University of California, Los Angeles, U.S. Public Health Service, University of California, San Francisco, National Heart, Lung, and Blood Institute, National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Center for Research Resources
Awards: LUPUS FAMILY REGISTRY AND REPOSITORY, G1029660433, RESEARCH RESOURCE FOR GENETICS OF FAMILIES/MULT, Genetic and functional studies of the CD40 P227A polymorphism, Vascular Disease in Systemic Lupus Erythematosus, Genetic Association in American Blacks with Lupus, TESTING SLE CANDIDATE LOCI USING CASES AND THEIR PARENTS, Identification of Susceptibility Genes for SLE of Amerindian Origin in Hispanics, G2060799175, G225186621, Comprehensive Candidate Pathway Analysis in SLE, Genetic Linkage in Lupus, General Clinical Research Center, G278114935, G2914221461, Genetic & Structure-Function Studies: Paraoxonase In SLE, Clinical and Transtional Science Institute, Molecular Mechanisms and Genetics of Autoimmunity, Prothrombin Gene Variation and the Risk of SLE and CHD, General Clinical Research Center, Molecular Genetics of BAT Genes and SLE Risk, Progression of Cardiovascular Disease in Lupus., Novel strategies for defining the role of HLA in SLE, General Clinical Research Center, G407776456, Fine Mapping and Replication of a Genome-Wide Association Scan for SLE in Hispani, G4444101046, Hopkins Lupus Cohort, Oklahoma Rheumatic Disease Research Cores Center, G4811145913, Immune/Inflammation Genomics and the Risk of SLE and CHD, G5070799704, G5179527739, Mapping Autoimmune Phenotypes in Multiplex Families, Comprehensive Candidate Pathway Analysis in SLE, An NCRR Center for High Throughput SNP Genotyping and Analysis, The Genetic Epidemiology of RA and SLE, GENETIC EPIDEMIOLOGY STUDY OF SLE IN FAMILIES, AUTOIMMUNE BIOMARKERS COLLABORATIVE NETWORK-264012256, Analysis of Apolipoprotein H in Lupus, G8856880592, Association of Positional Candidate Gene Variants with SLE, G9000062680, G9000091113, G9000169229, G9000271453, Genetic Linkage in Lupus
OpenAlex ID: W2139011450
